Delivering efficient liver-directed AAV-mediated gene therapy
Gene Ther
.
2017 May;24(5):263-264.
doi: 10.1038/gt.2016.90.
Epub 2017 Jan 12.
Authors
J Baruteau
1
2
3
,
S N Waddington
3
4
,
I E Alexander
5
6
,
P Gissen
1
2
7
Affiliations
1
Genetics and Genomic Medicine Programme, Great Ormond Street Institute of Child Health, University College London, London, UK.
2
Department of Metabolic Medicine, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
3
Maternal and Fetal Medicine, Gene Transfer Technology Group, Institute for Women's Health, University College London, London, UK.
4
Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of the Witswatersrand, Johannesburg, South Africa.
5
Gene Therapy Research Unit, The Children's Hospital at Westmead and Children's Medical Research Institute, Sydney, New South Wales, Australia.
6
Discipline of Child and Adolescent Health, The University of Sydney, Sydney, New South Wales, Australia.
7
MRC Laboratory for Molecular Biology, University College London, London, UK.
PMID:
28079048
DOI:
10.1038/gt.2016.90
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
MeSH terms
Animals
Dependovirus / genetics*
Genetic Therapy / methods*
Genetic Vectors / therapeutic use*
Humans
Liver / metabolism
Liver / physiology
Models, Animal
Grants and funding
MR/N019075/1/MRC_/Medical Research Council/United Kingdom